Kiwi, prunes and psyllium: what the comparison really showed.
A small, partially randomized four-week trial compared constipation responses without establishing a clear winner on its primary endpoint.

Illustrative food image, not a photograph of the study intervention.
Three options, one short comparison
Chey and colleagues’ 2021 exploratory trial compared green kiwifruit, prunes and psyllium in adults with chronic constipation at a US medical center. It was explicitly described as partially randomized, a qualification that should remain attached whenever the design is summarized. Seventy-nine patients entered, and complete data were available for 75. The intervention lasted four weeks. This was an active comparison between three options, not a long-term prevention study or a comparison with doing nothing. Two arms involved foods, while psyllium was a fiber supplement; calling all three “natural” does not erase that practical distinction.
Chey SW, Chey WD, Jackson K, Eswaran S.. The American journal of gastroenterology, 2021. PMID 34074830 · DOI
The primary endpoint was a responder measure
Eligible participants had no more than three complete spontaneous bowel movements per week. The primary endpoint was the proportion who increased that count by at least one per week relative to baseline for at least two of the four treatment weeks. The proportions meeting that definition were similar across treatments. That result is more specific than saying that one option was best for constipation. Similar response proportions in an exploratory study also do not, by themselves, prove formal equivalence. The responder threshold, the observation period and the between-group comparison all need to stay together when describing the main result.
Chey SW, Chey WD, Jackson K, Eswaran S.. The American journal of gastroenterology, 2021. PMID 34074830 · DOI
Secondary improvements need their labels
For the secondary analyses comparing treatment weeks three and four with baseline, weekly complete spontaneous bowel movement rates increased significantly in all three groups. Stool consistency improved significantly with kiwifruit and prunes, and straining improved significantly in all three groups. The kiwifruit group also reported significant improvement in bloating scores. These are useful symptom details, but they are not all interchangeable endpoints. In particular, improvement within a group compared with its own baseline is not automatically evidence of superiority over another group. Reporting the favorable secondary findings should not obscure the similar primary responder proportions.
Chey SW, Chey WD, Jackson K, Eswaran S.. The American journal of gastroenterology, 2021. PMID 34074830 · DOI
Tolerability and generalizability
Adverse events were most common with psyllium and least common with kiwifruit, and dissatisfaction at the end of treatment was less frequent in the kiwifruit group. Those findings add information beyond bowel frequency without making the study a universal ranking of whole foods against supplements. Participants had a mean age of 42.7 years; 87% were female and 77% were white. Together with the small sample, partial randomization and four-week duration, those features limit generalization. The report supports a carefully bounded comparison in chronic constipation, not a claim about all digestive symptoms, lifelong effects, or the outcomes of a recipe containing fruit. The study’s short observation period also separates an initial symptom response from sustained benefit. Neither the primary responder definition nor the tolerability comparison establishes what participants would experience over subsequent years.
Chey SW, Chey WD, Jackson K, Eswaran S.. The American journal of gastroenterology, 2021. PMID 34074830 · DOI